Recurrent

 

Treatment for recurrent liver cancer (cancer that has come back after it was first treated) depends on where the cancer recurred, the type of treatment you had the first time, and how healthy your liver is. If you have localized resectable disease in the same spot you had it the first time, you might be able to have surgery.

  • Partial hepatectomy - The surgeon removes the part of the liver where the cancer is located. This part could be a wedge of tissue, an entire lobe, or a larger portion of the liver. The surgeon also takes out some of the healthy tissue around the tumor.

    You can only have a partial hepatectomy if the part of your liver that is not affected by the cancer is working well. This is critical because after your doctor takes out the cancerous part of your liver, you need to have enough healthy liver tissue left to carry out all of the critical jobs of the liver.

If a partial hepatectomy is not an option for you, you might be a candidate for a liver transplant.

  • Total hepatectomy and liver transplant - The surgeon removes your entire liver (total hepatectomy) and replaces it with a healthy liver from a donor. After a transplant operation, you will take medications to prevent your body from rejecting the transplanted liver. Liver transplant is most effective in people with small tumors, and it can treat both the cancer and the liver disease that led to the cancer.

    A liver transplant is possible only when a donated liver is available. Relatively few livers are available for transplant into people with liver cancer because they are usually used for people with liver diseases that are more likely to be cured. In some cases, living donors give part of their liver for transplant to a close relative. However, this is risky for the donor and very few living donor transplants are done for patients with liver cancer in the United States.

If the cancer has spread from the liver to other parts of your body, you might be treated with chemotherapy. Regional chemotherapy is the most common way to deliver chemotherapy drugs for liver cancer. Other techniques are systemic chemotherapy and a newer technique, chemoembolization.

  • Systemic chemotherapy - Systemic chemotherapy affects the entire body. You take systematic chemotherapy drugs in pill form or by injection into the vein. Because they affect normal cells and cancer cells, these drugs often cause side effects, such as nausea, loss of hair, and fatigue. These side effects usually stop when you complete the chemotherapy treatment.
  • Regional (intra-arterial) chemotherapy - The doctor makes an incision under the ribs and places a small pump under the skin. The pump injects chemotherapy drugs into a thin tube that is placed in the hepatic artery, delivers oxygen-rich blood from the heart to the liver. This technique allows the doctor to deliver a much higher dose of chemotherapy directly into the liver with fewer side effects. Regional chemotherapy is used to treat liver cancer in patients who cannot have their cancer removed by surgery and those who have had their cancers removed but who are at high risk of having their liver cancer come back (recur). FUDR is the most commonly used drug for regional chemotherapy treatment of liver cancer.
  • Chemoembolization - The doctor threads a catheter (thin, flexible tube) into an artery in the inner thigh and up into the hepatic artery, which delivers oxygen-rich blood that tumors need to survive. The doctor then injects a dye into the bloodstream so that he or she can watch the dye move up the catheter using angiography, an x-ray procedure used to look at blood vessels. When the catheter reaches the liver, the doctor injects small particles containing chemotherapy into the hepatic artery. The particles block the flow of blood to the liver through the hepatic artery. Once the blood stops flowing, the tumor is soaked in a high concentration of chemotherapy drugs for a long time because no blood comes into the tumor to wash the drugs out. As a result, the tumor cells die very quickly. The procedure usually takes about 2 or 3 hours.
Another option is radiation therapy, which uses high-energy x-rays or other types of radiation to kill cancer cells. Radiation therapy can be given internally or externally.

  • Internal radiation therapy (brachytherapy or interstitial radiation therapy) - Tiny pellets (or “seeds”) that contain radioactive materials are injected into your bloodstream and guided to the hepatic artery. Tumor blood vessels are smaller than the blood vessels of healthy tissue. As a result, the seeds get stuck in the small blood cells that feed the tumors; however, they pass right through the larger blood vessels that feed healthy liver tissue. The pellets release their radiation slowly into the tumor without damaging healthy tissue. Brachytherapy lets the doctor use a higher dose of radiation than EBRT. This type of treatment involves a one-time procedure.
  • External beam radiation therapy (EBRT) - Radiation from a high-energy x-ray machine (linear accelerator) outside the body is focused on the cancer cells. EBRT can harm both the cancer cells and nearby healthy tissue. Most people are treated with EBRT for a few minutes 5 days a week for 3 to 5 weeks as an outpatient. This technique is rarely used for liver cancer.

Your doctor might recommend ablation or embolization of the tumor to treat your cancer symptoms. Ablation destroys the tumor without removing it. The doctor places needles into the tumors and kills the tissue next to the needles by injecting alcohol or by heating or freezing the cells. The placement of the needles is usually guided by CT scans or ultrasound. In some cases, the needle is inserted during surgery or laparoscopy. However, ablation is usually done by an intervention radiologist who inserts the needle directly into the skin.

The types of ablation used for liver cancer include:

  • Radiofrequency ablation - This technique uses thin electrodes that release high-frequency, alternating electrical current. The doctor inserts a probe into the center of the tumor. The probe pushes the electrodes, which are shaped like prongs, further into the tumor. The electrical current that flows from the electrodes heats the tumor to 80° C to 100° C (coagulative necrosis), which kills the cancer cells. Radiofrequency ablation can be used to treat small liver tumors that cannot be removed by surgery. It is also used to treat some of the symptoms of metastatic liver cancer.
  • Ethanol ablation (percutaneous ethanol injection, or PEI) - The doctor injects pure alcohol (ethanol) through a very thin needle into the tumor. The alcohol dries out the cancer cells, which kills them. Ethanol ablation can be used to treat small tumors or to reduce the symptoms of metastatic liver cancer. Five or six ethanol ablation sessions might be needed to completely destroy the cancer.
  • Cryosurgery (cryotherapy) - The doctor uses liquid nitrogen to cool a stainless steel probe (cryoprobe). The very cold probe is then inserted into the tumor, where it is left for 15 minutes. This cools the surrounding tissue to minus 190° C, which kills the cancer cells. The area is thawed for 10 minutes and then frozen again for another 15 minutes. This technique does not affect healthy liver cells, so it has very few side effects. Cryosurgery can kill larger tumors than radiofrequency ablation or ethanol ablation. It is sometimes used in combination with surgery, chemotherapy, or other treatments.

    Embolization stops blood from flowing to the tumor by injecting substances that plug the hepatic artery. This procedure does not affect healthy liver cells, which get their blood from the portal vein. The portal vein delivers blood that is rich in nutrients to the liver from the intestines. Like ablation, embolization is a good option for certain tumors that cannot be removed by surgery, especially if the cancer has not spread to other parts of the body.
  • Hepatic artery embolization - The doctor threads a catheter (thin, flexible tube) into an artery in the inner thigh and up into the hepatic artery. The doctor then injects a dye into the bloodstream so that he or she can watch the dye move up the catheter using angiography, an x-ray procedure used to look at blood vessels. When the catheter reaches the liver, the doctor injects small particles to plug the artery.

    Embolization reduces some of the blood supplied to normal liver tissue. This could be dangerous if you have hepatitis, cirrhosis, or another disease that affects the noncancerous part of the liver.

Embolization is sometimes combined with chemotherapy or radiation therapy.

  • Chemoembolization - The doctor threads a catheter (thin, flexible tube) into an artery in the inner thigh and up into the hepatic artery, which delivers oxygen-rich blood that tumors need to survive. The doctor then injects a dye into the bloodstream and watches the dye move up the catheter through angiography, an x-ray procedure used to look at blood vessels. When the catheter reaches the liver, the doctor injects small particles containing chemotherapy into the hepatic artery. The particles block the flow of blood to the liver through the hepatic artery. Once the blood stops flowing, the tumor is soaked in a high concentration of chemotherapy drugs for a long time because no blood comes into the tumor to wash the drugs out. As a result, the tumor cells die very quickly. The procedure usually takes about 2 or 3 hours.
  • Radioembolization - The doctor injects small radioactive beads or oils into the hepatic artery through the catheter. These beads or oils release small amounts of radiation to the tumor and do not affect healthy cells.
     

This content has been reviewed and approved by Myo Thant, MD.

This content was last modified on August 22, 2007 .
Latest Cancer News
Oncotype DX® Predicts Recurrence Risk in Node-negative and Node-positive Breast Cancer Treated with Tamoxifen or Anastrozole

March 10, 2010 — Researchers affiliated with the TransATAC Study have reported that the Oncotype DX® test predicts the risk of distant cancer recurrence in postmenopausal women with early, hormone receptor-positive breast cancer with both node-negative and node-positive disease treated with tamoxifen (Nolvadex®) or anastrozole (Arimidex®). These results were published early online in the Journal of Clinical Oncology on March 8, 2010.

Recent Results of High-dose Proleukin® for Metastatic Renal Cell Carcinoma Reported

March 10, 2010 — Researchers involved in a U.S. multicenter trial (Cytokine Working Group) have reported that high-dose Proleukin® (aldesleukin, interleukin-2, IL-2) results in a higher response rate in patients with metastatic renal cell carcinoma (MRCC) than historically reported. The details of this study were presented at the 2010 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, March 5-7, in San Francisco.

Cystoscopy Remains Best Method for Surveillance of Patients with Bladder Cancer

March 10, 2010 — Researchers from the M. D. Anderson Cancer Center have reported that cystoscopy alone remains the most cost-effective method of detecting recurrent superficial bladder cancer. The details of this study were presented at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium March 5-7 in San Francisco.

Select news items provided by Reuters Health